Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE 12 ( December, 2022 ) > List of Articles

Original Article

New Antibiotic Prescription Pattern in Critically Ill Patients (“Ant-critic”): Prospective Observational Study from an Indian Intensive Care Unit

Ripenmeet Salhotra, Garima Arora, Niranjan Kumar

Keywords : Antibiotic(s), Intensive care unit, Patient outcome, Prescription process

Citation Information : Salhotra R, Arora G, Kumar N. New Antibiotic Prescription Pattern in Critically Ill Patients (“Ant-critic”): Prospective Observational Study from an Indian Intensive Care Unit. Indian J Crit Care Med 2022; 26 (12):1275-1284.

DOI: 10.5005/jp-journals-10071-24366

License: CC BY-NC 4.0

Published Online: 08-12-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Introduction: This study aimed to address the issue of antibiotic prescription processes in an Indian Intensive care unit (ICUs). Materials and methods:: In a prospective longitudinal study, all adult patients admitted in the ICU for 24 hours or above between 01 June 2020 and 31 July 2021 were screened for any new antibiotic prescription throughout their ICU stay. All new antibiotic prescriptions were assessed for baseline variables at prescription, any modifications during the course, and the outcome of antibiotic prescription. Results: A total of 1014 patients fulfilled entry criteria; 59.2 and 7.2% of days they were on a therapeutic or prophylactic antibiotic(s). Patients, who were prescribed therapeutic antibiotic(s), had worse ICU outcomes. A total of 49.5% of patients (502 of 1,014) received a total of 552 new antibiotic prescriptions during their ICU stay. About 92.13% of these prescriptions were empirical and blood or other specimens were sent for culture in 78.81 and 60.04% of instances. A total of 31.7% of episodes were microbiologically proven and were more likely to be prescribed by an ICU consultant. A total of 169 modifications were done in 142 prescription episodes; 73 of them after sensitivity results. Thus, the overall rate of de-escalation was 13.95%. Apart from the negative culture result (36.05%), an important reason for a relatively low rate of de-escalation was the absence of sampling (12.32%). Longer ICU stay before antibiotic prescription, underlying chronic liver disease (CLD), worse organ dysfunction, and septic shock were independently associated with unfavorable treatment outcomes. No such independent association was observed between antibiotic appropriateness and patient outcome. Conclusion: Future antibiotic stewardship strategies should address issues of high empirical prescription and poor microbiological sampling hindering the de-escalation process.

  1. Ghosh S, Singh A. Principle of antimicrobial uses. In: Mehta Y, Sharma J, Mehta C (Editors). Textbook of Critical Care, 2nd edition. New Delhi: Jaypee Brothers Medical Publishers, 2022, pp.775–782.
  2. Lehmann LE, Hunfeld KP, Steinbrucker M, Brade V, Book M, Seifert H, et al. Improved detection of blood stream pathogens by real-time PCR in severe sepsis. Intensive Care Med 2009;36(1):49–56. DOI: 10.1007/s00134-009-1608-z.
  3. Emmerson M. Antibiotic usage and prescribing policies in the intensive care unit. Intensive Care Med 2000;26(Suppl. 1):S26–S30. DOI: 10.1007/s001340051115.
  4. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34(6):1589–1596. DOI: 10.1097/01.CCM.0000217961.75225.E9.
  5. Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, et al. Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 2011;39(9): 2066–2071. DOI: 10.1097/CCM.0b013e31821e87ab.
  6. Sterling SA, Miller WR, Pryor J, Puskarich MA, Jones AE. The impact of timing of antibiotics on outcomes in severe sepsis and septic shock: A systematic review and meta-analysis. Crit Care Med 2015;43(9): 1907–1915. DOI: 10.1097/CCM.0000000000001142.
  7. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47(11):1–67. DOI: 10.1007/s00134-021-06506-y.
  8. Rhee C, Gohil S, Klompas M. Regulatory mandates for sepsis care: Reasons for caution. N Engl J Med 2014;370(18):1673–1676. DOI: 10.1056/NEJMp1400276.
  9. Paterson DL, Rice LB. Empirical antibiotic choice for the seriously ill patient: Are minimization for selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin Infect Dis 2003;36(8):1006–1012. DOI: 10.1086/374243.
  10. Bergmans DC, Bonten MJ, Gaillard CA, van Tiel FH, van der Geest S, de Leeuw PW, et al. Indications for antibiotic use in ICU patients: a one-year prospective surveillance. J Antimicrob Chemother 1997;39(4):527–535. DOI: 10.1093/jac/39.4.527.
  11. Warren MM, Gibb AP, Walsh TS. Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: A prospective audit in a large UK teaching hospital. J Hosp Infect 2005;59(2):90–95. DOI: 10.1016/j.jhin.2004.09.014.
  12. Erbay A, Bodur H, Akinci E, Colpan A. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. J Hosp Infect 2005;59(1):53–61. DOI: 10.1016/j.jhin.2004.07.026.
  13. Erlandsson M, Burman LG, Cars O, Gill H, Nilsson LE, Walther SM, et al. Prescription of antibiotic agents in Swedish intensive care units is empiric and precise. Scand J Infect Dis 2007; 39:63–69. DOI: 10.1080/00365540600740504.
  14. Montravers P, Dupont H, Gauzit R, Veber B, Bedos JP, Lepape A, et al. Strategies of initiation and streamlining of antibiotic therapy in 41 French intensive care units. Crit Care 2011;15(1):R17. DOI: 10.1186/cc9961.
  15. Ghafur A, Mathai D, Muruganathan A, Jayalal JA, Kant R, Chaudhary D, et al. The Chennai Declaration: A roadmap to tackle the challenge of antimicrobial resistance. Indian J Cancer 2012;50(1):71–73. DOI: 10.4103/0019-509X.104065.
  16. Divatia JV, Amin PR, Ramakrishnan N, Kapadia FN, Todi S, Sahu S, et al. Intensive care in India: The Indian intensive care case mix and practice patterns study. Indian J Crit Care Med 2016;20(4):216–225. DOI: 10.4103/0972-5229.180042.
  17. Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, et al. Antimicrobial de-escalation in critically ill patients: A position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP). Intensive Care Med 2019;46(2):245–265. DOI: 10.1007/s00134-019-05866-w.
  18. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial. Lancet 2010;375(9713):463–474. DOI: 10.1016/S0140-6736(09)61879-1.
  19. Naikwadi IB, Baig SM, Bhattacharya M. To study the prescription pattern of antibiotics in medicine intensive care unit at tertiary care hospital. Int J Basic Clin Pharmacol 2019;8:738–745.
  20. Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med 2016;13(3):e1001974. DOI: 10.1371/journal.pmed.1001974.
  21. Walia K, Madhumathi J, Veeraraghavan B, Chakrabarti A, Kapil A, Ray P, et al. Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far. Indian J Med Res 2019;149(2):164–179. DOI: 10.4103/ijmr.IJMR_226_18.
  22. Pathak A, Chandran SP, Mahadik K, Macaden R, Lundborg CS. Frequency and factors associated with carriage of multidrug resistant commensal Escherichia coli among women attending antenatal clinics in central India. BMC Infect Dis 2013;13:199. DOI: 10.1186/1471-2334-13-199.
  23. Tabah A, Cotta MO, Garnacho–Montero J, Schouten J, Roberts JA, Lipman J, et al. A systematic review of the definitions, determinants, and clinical outcomes of antimicrobial de-escalation in the intensive care unit. Clin Infect Dis 2016;62(8):1009–1017. DOI: 10.1093/cid/civ1199.
  24. De Bus L, Depuydt P, Steen J, Dhaese S, De Smet K, Tabah A, et al. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: The DIANA study. Intensive Care Med 2020;46(7): 1404–1417. DOI: 10.1007/s00134-020-06111-5.
  25. Marquet K, Liesenborgs A, Bergs J, Vleugels A, Claes N. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: A systematic review and meta-analysis. Crit Care 2015;19(1);63. DOI: 10.1186/s13054-015-0795-y.
  26. Kadri SS, Lai YL, Warner S, Strich JR, Babiker A, Ricotta EE, et al. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in vitro susceptibilities: A retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis 2021;21:241–251. DOI: 10.1016/S1473-3099(20)30477-1.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.